Work

P3.13.12 Multi-Institution Analysis Evaluating Safety, Efficacy and ctDNA Dynamics Following Tarlatamab in ES-SCLC and LCNEC Patients

FWCI: 0.591
Cites:
Cited by: 1
Related to: